Neurodegenerative Drugs Market to Reach $74.8 Billion by 2031, Driven by Rising Alzheimer's and Parkinson's Cases

𝐆𝐥𝐨𝐛𝐚𝐥 𝐍𝐞𝐮𝐫𝐨𝐝𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐫𝐨𝐰𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬

Know More: https://www.alliedmarketresearch.com/neurodegenerative-drugs-market-A13213

The global neurodegenerative drugs market is on a robust growth trajectory, driven by an increasing prevalence of neurological disorders and advancements in treatments. Here's an overview of the key factors shaping this dynamic market.

Market Overview
• Market Value: Valued at $36,277.20 million in 2021, the market is projected to reach $74,809.38 million by 2031.
• Growth Rate: Expected to grow at a CAGR of 7.5% from 2022 to 2031.
• Key Conditions Treated: Alzheimer's disease, Parkinson's disease, multiple sclerosis (MS), and Huntington's disease.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A13213

Market Drivers
• Rising Prevalence of Neurodegenerative Diseases: Increasing cases of Alzheimer's, Parkinson's, and MS are spurring demand for effective drug therapies.
• Emerging Markets Potential: Untapped regions with improving healthcare infrastructure and higher chronic disease rates present significant opportunities for market expansion.
• Government and Organizational Investments: Increased funding for research and development (R&D) by governments, pharmaceutical companies, and non-profits is facilitating new treatment discoveries.

Challenges
• High R&D Costs: Developing neurodegenerative drugs is expensive, limiting new entrants and reducing the number of new drugs brought to market.
• Regulatory Delays: Lengthy and costly approval processes for new drugs slow down market entry and patient access.

Segmental Breakdown
• By Drug Class:
• Dopamine Agonists, Decarboxylase Inhibitors, Cholinesterase Inhibitors, Immunomodulators, Others: Decarboxylase inhibitors expected to see the highest growth due to their role in reducing side effects in dopamine therapy.

• By Indication:
• Multiple Sclerosis Dominates: This segment leads in market share due to the rising number of patients.
• Parkinson's Disease: Expected to register the highest growth, supported by increasing diagnosis rates globally.
• By Distribution Channel:
• Drug Stores & Retail Pharmacies: Largest market share in 2021, driven by the rising demand for neurological disorder treatments.
• Online Providers: Fastest-growing segment, boosted by convenience, lower prices, and accessibility.

Regional Insights
• North America: Dominated the market in 2021, supported by major pharmaceutical players and strong healthcare infrastructure.
• Asia-Pacific: Expected to witness the fastest growth, attributed to the region's growing pharmaceutical industry, increased spending on personalized medicine, and high purchasing power in populous countries like China and India.

Competitive Landscape
Key players in the market include:
• AbbVie Inc.
• Biogen
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Sanofi
• Teva Pharmaceutical Industries Ltd.

These companies focus on strategic collaborations, acquisitions, and new product approvals to expand their market presence.

The global neurodegenerative drugs market is poised for significant growth, driven by advances in drug therapies, increased R&D investments, and the rising prevalence of neurological diseases. However, challenges like high R&D costs and regulatory hurdles need to be addressed to ensure faster market expansion.

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A13213

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports Insights" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
1209 Orange Street
Corporation Trust Center
Wilmington
New Castle
Delaware 19801
USA Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

This release was published on openPR.